Milestone Pharmaceuticals (MIST) Assets (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Assets of $193.7 million for Q1 2026, up 70.6% on a QoQ basis from $113.6 million in Q4 2025, and up 213.05% year-over-year from $61.9 million in Q1 2025.
Milestone Pharmaceuticals (MIST) Assets (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Assets history runs 9 years deep, the most recent figure standing at $193.7 million for Q1 2026.
- Quarterly Assets rose 213.05% year-over-year to $193.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193.7 million (up 213.05% YoY) and the FY2025 annual result came in at $113.6 million, up 50.41% from the prior year.
- Assets was $193.7 million for Q1 2026 at Milestone Pharmaceuticals, up from $113.6 million in the prior quarter.
- Across five years, Assets topped out at $193.7 million in Q1 2026 and bottomed at $47.4 million in Q2 2025.
- A 5-year average of $92.7 million and a median of $87.8 million in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2025 — Assets slumped 46.86% — and 2026, when it surged 213.05%.
- Milestone Pharmaceuticals' Assets stood at $74.5 million in 2022, then grew by 1.0% to $75.2 million in 2023, then climbed by 0.36% to $75.5 million in 2024, then jumped by 50.41% to $113.6 million in 2025, then soared by 70.6% to $193.7 million in 2026.
- Business Quant data shows MIST's Assets at $193.7 million in Q1 2026, $113.6 million in Q4 2025, and $87.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | 193.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193.73 Mn |
| Dec 31, 2025 | 113.56 Mn |
| Sep 30, 2025 | 87.75 Mn |
| Jun 30, 2025 | 47.42 Mn |
| Mar 31, 2025 | 61.89 Mn |
| Dec 31, 2024 | 75.50 Mn |
| Sep 30, 2024 | 82.71 Mn |
| Jun 30, 2024 | 89.23 Mn |
| Mar 31, 2024 | 96.00 Mn |
| Dec 31, 2023 | 75.23 Mn |
| Sep 30, 2023 | 87.12 Mn |
| Jun 30, 2023 | 97.02 Mn |
| Mar 31, 2023 | 111.08 Mn |
| Dec 31, 2022 | 74.48 Mn |
| Sep 30, 2022 | 85.77 Mn |
| Jun 30, 2022 | 91.30 Mn |
| Mar 31, 2022 | 105.80 Mn |
| Dec 31, 2021 | 119.85 Mn |
| Sep 30, 2021 | 133.78 Mn |
| Jun 30, 2021 | 145.50 Mn |